Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Open-market buy Director bought 1,000,000 shares at $2.50 ($2,500,000)
  2. 4 Open-market sale Chief Commercial Officer sold 30,000 shares at an average $3.07 ($91,980)
  3. 4 Open-market buy Director bought 300,000 shares at $2.45 ($735,000)
  4. 4 Open-market sale Director sold 300,000 shares at $2.45 ($735,000)
  5. 4 Open-market buy Director bought 300,000 shares at $2.44 ($730,500)
  6. 4 Open-market sale Director sold 300,000 shares at $2.44 ($730,500)
  7. 4 Open-market buy Director bought 2,000,000 shares at $2.52 ($5,040,000)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 500,000 shares at $3.74 ($1,870,000)
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 4 Exercise or conversion Sr. VP, COO, and CFO acquired 25,000 shares (option exercise)
  19. 4 Open-market buy Director bought 300,042 shares at an average $3.51 ($1,052,148)
  20. 4 Open-market sale Chief Commercial Officer sold 13,860 shares at an average $3.76 ($52,058)

Page 16 of 37 · 722 filings